BCL2 and acute lymphoblastic leukemia: Hyperactivation of TYK2 pathway, either through mutations or other mechanisms, has been shown to contribute to aberrant cell survival through upregulation of the anti-apoptotic protein BCL2 in several T-ALL-cell lines [34].